Announcement • May 02
Common Shares of GBLT Corp. to Be Delisted from the TSX Venture Exchange Effective at the close of business on May 13, 2024, the common shares of GBLT Corp. will be delisted from the TSX Venture Exchange at the request of the Company. The Company obtained the director's resolution on February07, 2024, authorizing the delist. The Company's majority of minority shareholders approved the delisting pursuant to an annual general and special meeting of shareholders held on April 26, 2024. Announcement • Feb 01
An unknown buyers acquired 29.1% stake in GBLT Corp. (TSXV:GBLT) from SWT Beteiligungs AG for CAD 1.3 million. An unknown buyers acquired 29.1% stake in GBLT Corp. (TSXV:GBLT) from SWT Beteiligungs AG for CAD 1.3 million on January 29, 2024. SWT sold an aggregate of 33 million common shares.
An unknown buyers completed the acquisition of 29.1% stake in GBLT Corp. (TSXV:GBLT) from SWT Beteiligungs AG on January 29, 2024. Announcement • Jan 16
GBLT Corp., Annual General Meeting, Mar 22, 2024 GBLT Corp., Annual General Meeting, Mar 22, 2024. Reported Earnings • Dec 01
Third quarter 2023 earnings released: EPS: €0 (vs €0 in 3Q 2022) Third quarter 2023 results: EPS: €0 (in line with 3Q 2022). Revenue: €8.24m (down 40% from 3Q 2022). Net income: €40.3k (up 90% from 3Q 2022). Profit margin: 0.5% (up from 0.2% in 3Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 68 percentage points per year, which is a significant difference in performance. Announcement • Nov 10
n unknown buyer signed an agreement to acquire 50% plus 1 interest in Gebäude Technologie Center Gmbh from GBLT Corp (TSXV : GBLT) for €0.03 million. An unknown buyer signed an agreement to acquire 50% plus 1 interest in Gebäude Technologie Center Gmbh from GBLT Corp (TSXV : GBLT) for €0.03 million on November 8, 2023. Reported Earnings • Sep 01
Second quarter 2023 earnings released: €0.002 loss per share (vs €0.007 profit in 2Q 2022) Second quarter 2023 results: €0.002 loss per share (down from €0.007 profit in 2Q 2022). Revenue: €4.13m (down 59% from 2Q 2022). Net loss: €197.0k (down 125% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings. New Risk • Jul 13
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Canadian stocks, typically moving 18% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Negative equity (-€890k). Market cap is less than US$10m (CA$6.80m market cap, or US$5.16m). Reported Earnings • May 07
Full year 2022 earnings released: EPS: €0.002 (vs €0.002 loss in FY 2021) Full year 2022 results: EPS: €0.002 (up from €0.002 loss in FY 2021). Revenue: €39.7m (up 28% from FY 2021). Net income: €173.2k (up €347.0k from FY 2021). Profit margin: 0.4% (up from net loss in FY 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 59% per year whereas the company’s share price has increased by 56% per year. Reported Earnings • Nov 29
Third quarter 2022 earnings released: EPS: €0 (vs €0 in 3Q 2021) Third quarter 2022 results: EPS: €0 (in line with 3Q 2021). Revenue: €13.6m (up 74% from 3Q 2021). Net income: €21.2k (down 44% from 3Q 2021). Profit margin: 0.2% (down from 0.5% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Independent Director Alfred Schopf was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Announcement • Sep 08
GBLT Corp. Announces Global Expansion of Its Dr. Senst Healthcare Products GBLT Corp. announced the expansion of its Dr. Senst product line. GBLT continues to globalize its personal healthcare brand and gain additional retail shelf presence. Dr. Senst will introduce 11 new products ranging from light therapy lamps to nasal aspirators covering a wide variety of personal healthcare needs ranging from mental health to physical pain relief. Reported Earnings • Aug 24
Second quarter 2022 earnings released: EPS: €0.007 (vs €0.001 in 2Q 2021) Second quarter 2022 results: EPS: €0.007 (up from €0.001 in 2Q 2021). Revenue: €10.1m (up 55% from 2Q 2021). Net income: €779.1k (up €713.9k from 2Q 2021). Profit margin: 7.7% (up from 1.0% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. Announcement • Jun 03
GBLT Corp., Annual General Meeting, Jul 14, 2022 GBLT Corp., Annual General Meeting, Jul 14, 2022. Reported Earnings • May 31
First quarter 2022 earnings released: EPS: €0 (vs €0.004 in 1Q 2021) First quarter 2022 results: EPS: €0 (down from €0.004 in 1Q 2021). Revenue: €8.04m (down 8.8% from 1Q 2021). Net loss: €17.8k (down 104% from profit in 1Q 2021). Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 22% per year, which means it is significantly lagging earnings. Reported Earnings • Apr 29
Full year 2021 earnings released: €0.002 loss per share (vs €0.005 profit in FY 2020) Full year 2021 results: €0.002 loss per share (down from €0.005 profit in FY 2020). Revenue: €31.1m (up 31% from FY 2020). Net loss: €173.8k (down 133% from profit in FY 2020). Over the last 3 years on average, earnings per share has increased by 100% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings. Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. President, CEO & Director Joachim Senst was the last director to join the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Board Change • Jan 14
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. President, CEO & Director Joachim Senst was the last director to join the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Announcement • Jan 12
GBLT Corp. (TSXV:GBLT) acquired an unknown majority stake in Gebäude Technologie Center Gmbh. GBLT Corp. (TSXV:GBLT) acquired an unknown majority stake in Gebäude Technologie Center Gmbh on January 11, 2022.
GBLT Corp. (TSXV:GBLT) completed the acquisition of an unknown majority stake in Gebäude Technologie Center Gmbh on January 11, 2022. Reported Earnings • Aug 26
Second quarter 2021 earnings released: EPS €0.001 (vs €0.005 in 2Q 2020) The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €6.50m (down 8.9% from 2Q 2020). Net income: €65.2k (down 89% from 2Q 2020). Profit margin: 1.0% (down from 8.6% in 2Q 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 115% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Reported Earnings • May 21
First quarter 2021 earnings released: EPS €0.004 (vs €0.002 loss in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €8.82m (up 234% from 1Q 2020). Net income: €401.7k (up €647.2k from 1Q 2020). Profit margin: 4.6% (up from net loss in 1Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 110% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. Reported Earnings • May 03
Full year 2020 earnings released: EPS €0.005 (vs €0.01 loss in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: €23.8m (up 17% from FY 2019). Net income: €527.5k (up €1.63m from FY 2019). Profit margin: 2.2% (up from net loss in FY 2019). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 94% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Announcement • Mar 14
GBLT Corp. Announces Initial EUR 200,000 Order GBLT Corp. in partnership with German engineering firm Gebäude Technologie Center GmbH, will deliver solar panel hardware to one of Europe's largest chemicals & consumer goods companies that surpasses EUR 25 billion in turnover annually. The initial order received is for EUR 200,000 and is expected
to grow to a total of EUR 500,000 over the remaining parts of 2021. Announcement • Mar 04
GBLT Receives Initial Order for its Proprietary Line of Disinfectant Products GBLT Corp. announced that it has received the first order for its previously announced disinfectant line of products from one of Europe retailers for internal use. The Dr. Senst branded products includes lines of sprays and wipes up to 99.99% effectiveness in killing bacteria and germs. The initial order is for 24,000 packs, each containing 60 wipes, and will be used by the retailer for internal use only in Germany, including production facilities, storage facilities and retail stores. The Company anticipates additional orders from this client over the coming months. Conventional disinfectants are immediately effective but only for a short period of time. Dr. Senst's branded disinfectants are able to last up to 10 days as a result of its proprietary anti-microbial effect. Dr. Senst surface disinfection establishes an ultrathin film with a lasting effect. Using sol-gel technology, the biocides used to kill the germs are embedded in the porous structure of the developing sponge-like sol-gel and are washed out again when coming into contact with water. Announcement • Feb 19
GBLT Corp. Receives $2.7 Million Follow-On Order from European Mass Merchandiser for Private Battery Label GBLT Corp. announced that it has received a follow-on order of $2.7 million from one of Europe's biggest mass merchandisers to provide private label batteries. This merchandiser had previously placed an order for $4.8 million as announced on January 21st, 2021 and has now placed a follow-on order due to overwhelming customer demand. In addition to AgfaPhoto branded batteries and mobile energy products, GBLT delivers private label batteries that vendors can brand their own. This is often done to provide an alternative to more expensive, brand-named batteries for consumers that are seeking a cheaper product. This allows retailers to solidify their own brand awareness with consumers. Announcement • Feb 03
GBLT Corp. Expands PPE Suite of Products Under the Dr. Senst Brand GBLT Corp. announced that the Company has added a proprietary line of insect repellent products to its Dr. Senst brand of Personal Protective Equipment ("PPE") solutions. The addition of this new and innovative product line results from successful adoption and strong brand loyalty from existing Dr. Senst branded PPE products, including thermometers and masks, that are currently for sale through Europe's retailers. Dr. Senst branded insect repellent offers a patented depot effect that prevents bug bites for up to 24 hours, making it one of the longest lasting solutions available on the market. The Company will offer three initial products at launch: Dr. Senst Mosquito Stop Scent Screen: A proprietary cream blend that can be applied to the skin directly. The blend has a lasting impact of up to 9 hours and has been dermatologically tested. Dr. Senst Mosquito-Tick Protection: A spray on solution that lasts up to 24 hours and is effective against both mosquito and ticks. This proprietary blend is enriched with high-quality skincare treaments and is 100% DEET free. Dr. Senst Stitch Acute: A proprietary afterbite solution that relives, disinfects and cares for the affected skin area. Announcement • Jan 22
GBLT Corp. Receives USD 4.8 Million Contract with European Mass Merchandiser for Private Battery Label GBLT Corp. announced that it has received an order of USD 4.8 million from one of Europe's biggest mass merchandisers to provide private label batteries. This merchandiser had previously been a client of GBLT's however this is the first time they have selected GBLT as a vendor without having an open tender process. In addition to AgfaPhoto branded batteries and mobile energy products, GBLT delivers private label batteries that vendors can brand their own. This is often done to provide an alternative to more expensive, brand-named batteries for consumers that are seeking a cheaper product. This allows retailers to solidify their own brand awareness with consumers. Announcement • Jan 20
GBLT Corp. Receives an Order of EUR 1.4 Million for Dr. Senst Branded Thermometers GBLT Corp. announced that it has received an order of EUR 1.4 million for Dr. Senst branded thermometers from one of Europe's largest retailer chains. GBLT anticipates delivering this order in late first quarter of 2021 and into early second quarter of 2021. This is the company's third order for thermometers from this major retailer, with GBLT now having received a total of 2.8 million in thermometer orders from this client. This third order will see Dr. Senst branded thermometers delivered to European countries that had not been previously carrying the Dr. Senst brand. This continues a planned expansion by the retailer of Dr. Senst Personal Protective Equipment into stores throughout Europe for their chain of stores. The company anticipates additional orders throughout the remainder of this year as well as continued delivery of FFP2 masks. Is New 90 Day High Low • Jan 20
New 90-day high: CA$0.32 The company is up 250% from its price of CA$0.09 on 21 October 2020. The Canadian market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electrical industry, which is up 88% over the same period. Announcement • Jan 14
GBLT Corp. Receives €195,000 in PPE Orders from German Retailers and Announces Launch of Online Strategy for Mobile Energy GBLT Corp. announce that it has received orders of €195,000 in Dr. Senst branded FFP2 masks from two major German retailers. GBLT had previously been delivering masks to both retailers, with one previously referenced in news releases issued December 2nd, 2020 and December 10th, 2020. The second order, included in the €195,000 figure, comes from an existing retailer customer that had previously been ordering standard masks, and is now upgrading to FFP2 masks. FFP2 masks are considered professional and medical grade masks compared to the FFP1 masks that are more commonly found throughout European regions. FFP2 masks are considered better for self protection against airborne viruses compared to FFP1 which only limit the spread of an iillness. The Company is also pleased to announced that it has expanded its mobile energy business to include online sales with some of Europe's largest online distributers. The management believes that this online strategy will yield promising results going forward. Is New 90 Day High Low • Dec 30
New 90-day high: CA$0.26 The company is up 292% from its price of CA$0.065 on 30 September 2020. The Canadian market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electrical industry, which is up 48% over the same period. Is New 90 Day High Low • Dec 17
New 90-day high: CA$0.22 The company is up 340% from its price of CA$0.05 on 16 September 2020. The Canadian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electrical industry, which is up 20% over the same period. Announcement • Dec 17
GBLT Corp. Signs 700,000 Order with Retailer for Thermometers GBLT Corp. announced that one of Europe's retailers has ordered 700,000 of Dr. Senst thermometers to be delivered in January 2021. This is the Company's first order for thermometers with this major retailer and is a new product line in GBLT's previously announced expansion into PPE solutions. GBLT is a listed supplier for this major European retailer and this is now the second product that they are delivering with the first being masks. This initial order of GBLT's themometers will be placed in stores across one European nation and online distribution of this major retailer. Upon delivery of this order by end of January, the Company expects follow-on orders for additional European countries with this retailer. Reported Earnings • Dec 04
Third quarter 2020 earnings released: EPS €0.005 The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: €9.75m (up 47% from 3Q 2019). Net income: €575.6k (up €633.0k from 3Q 2019). Profit margin: 5.9% (up from net loss in 3Q 2019). The move to profitability was driven by higher revenue. Announcement • Dec 03
GBLT Corp. Adds New Major Retailer to Growing Client List GBLT Corp. announced that the Company has added a major European retailer as its latest client purchasing Personal Protective Equipment ("PPE"). The German retailer has 222 physical stores throughout Germany and has placed an order for 25,000 FFP2. This is GBLT's first listed product with the retailer and as a listed vendor, the retailer is able to quickly add further GBLT products to shelves as they see fit including mobile energy and battery solutions. FFP2 masks are considered professional and medical grade masks compared to the FFP1 masks that are more commonly found throughout European regions. FFP2 have filter capacity of approximately 94%, comparable to the North American standard masks of N95 that offer filter capacity of 95%, relative to FFP1 masks that have an 80% filter capacity. Reported Earnings • Dec 02
Third quarter 2020 earnings released: EPS €0.005 The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: €9.75m (up 47% from 3Q 2019). Net income: €575.6k (up €632.5k from 3Q 2019). Profit margin: 5.9% (up from net loss in 3Q 2019). The move to profitability was driven by higher revenue. Announcement • Nov 25
GBLT Corp. Expands Relationship with One of Europe's Largest Drug-Store Retailers to Offer PPE GBLT Corp. announced that the Company has delivered an order of 50,000 FFP2 masks to an existing drug-store client. This is the second new product line that GBLT has introduced to the retailer in 2020, with the first order of flash media cards as announced on October 21st, 2020. FFP2 masks are considered professional and medical grade masks compared to the FFP1 masks that are more commonly found throughout European regions. FFP2 have filter capacity of approximately 94%, comparable to the North American standard masks of N95 that offer filter capacity of 95%, relative to FFP1 masks that have an 80% filter capacity. Announcement • Nov 19
GBLT Corp. Introduces New Line of Patent-Protected Disinfectant Products GBLT Corp. announced that the Company has launched a new line of patent-protected disinfectant products under the Dr. Senst brand of Personal Protection Equipment (PPE) solutions. The product line includes hand sanitizers, disinfection wipes and sprays for surface areas. All products have been developed under a medical grade standard as they exceed a 99.99% effectiveness rate compared to many competitors that typically offer only 99.9% effectiveness. Conventional disinfectants are immediately effective but only for a short period of time. Dr. Senst's branded disinfectants are able to last up to 10-days as a result of its proprietary anti-microbial effect. Dr. Senst Surface Disinfection establishes an ultra-thin film with a lasting effect. Using sol-gel technology, the biocides used to kill the germs are embedded in the porous structure of the developing sponge-like sol-gel and are washed out again when coming into contact with water. The number of infections from microorganisms has increased rapidly over the past several years along with the outbreak of infectious diseases and viruses such as COVID-19, H1N1 and Ebola. Up to 800,000 patients fall ill every year on nosocomial infections in German hospitals alone. Methicillian-resistant Staphylococcus aureus (MRSA) infections have risen dramatically from 1.7% in 1990 to in excess of 20% in developed countries. Due to these factors, the disinfectant market continues to grow drastically and new and novel solutions are required to address this market. Announcement • Nov 17
GBLT Corp., Annual General Meeting, Jan 12, 2021 GBLT Corp., Annual General Meeting, Jan 12, 2021. Reported Earnings • Sep 29
First half earnings released Over the last 12 months the company has reported total losses of €682.8k, with earnings decreasing by €723.6k from the prior year. Total revenue was €21.9m over the last 12 months, up 6.1% from the prior year. Announcement • Sep 26
GBLT Receives €275,000 Order with Office Supply Retailer GBLT Corp. announced that it has received an order from a French office supply company Alterburo for €275,000. GBLT will deliver its unique Dr. Senst brand of protective masks and anticipates follow-up orders from Alterburo upon full turnover of this first order. As a result of the COVID-19 pandemic, GBLT entered into the PPE industry in March of this year to match demand from existing and new clients for products such as masks, sanitizers and thermometers. Due to sustained demand from the existing distribution network, GBLT has relaunched its Dr. Senst brand of products to offer distributers and retailers a branded, trusted solution. Announcement • Jun 17
GBLT Corp. Auditor Raises 'Going Concern' Doubt GBLT Corp. filed its Annual on Jun 12, 2020 for the period ending Dec 31, 2019. In this report its auditor, Dale Matheson Carr-Hilton, gave an unqualified opinion expressing doubt that the company can continue as a going concern. 
